ID   THIO_HUMAN              Reviewed;         105 AA.
AC   P10599; B1ALW1; O60744; Q53X69; Q96KI3; Q9UDG5;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 206.
DE   RecName: Full=Thioredoxin;
DE            Short=Trx;
DE   AltName: Full=ATL-derived factor;
DE            Short=ADF;
DE   AltName: Full=Surface-associated sulphydryl protein;
DE            Short=SASP;
GN   Name=TXN; Synonyms=TRDX, TRX, TRX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3170595;
RA   Wollman E.E., D'Auriol L., Rimsky L., Shaw A., Jacquot J.-P.,
RA   Wingfield P., Graber P., Dessarps F.;
RT   "Cloning and expression of a cDNA for human thioredoxin.";
RL   J. Biol. Chem. 263:15506-15512(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2785919;
RA   Tagaya Y., Maeda Y., Mitsui A., Kndo N., Matsui H., Hamuro J.,
RA   Brown N., Arai K., Yokota T., Wakasugi H., Yodoi J.;
RT   "ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to
RT   thioredoxin; possible involvement of dithiol-reduction in the IL-2
RT   receptor induction.";
RL   EMBO J. 8:757-764(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1874447; DOI=10.1016/0378-1119(91)90081-L;
RA   Tonissen K.F., Wells J.R.E.;
RT   "Isolation and characterization of human thioredoxin-encoding genes.";
RL   Gene 102:221-228(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lens;
RA   Reddy P.G., Bhuyan D.K., Bhuyan K.C.;
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lens;
RA   Liu A., Lou M.F.;
RT   "Cloning, purification and characterization of human lens
RT   thioredoxin.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Xu J.Y., Xu L., Li K.S., Dai R.;
RT   "Cloning and sequencing of thioredoxin cDNA from human brain.";
RL   Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-85 (ISOFORM 2), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Liver;
RA   Wang Y., Wang Y.G., Zhang Y., Yuan Y., Ma D.;
RT   "An alternative splice variant of human thioredoxin.";
RL   Chin. Sci. Bull. 43:292-295(1998).
RN   [14]
RP   PROTEIN SEQUENCE OF 2-21 AND 38-57.
RC   TISSUE=Monocyte;
RX   PubMed=7818492; DOI=10.1042/bj3040861;
RA   Dean M.F., Martin H., Sansom P.A.;
RT   "Characterization of a thioredoxin-related surface protein.";
RL   Biochem. J. 304:861-867(1994).
RN   [15]
RP   PROTEIN SEQUENCE OF 2-15.
RX   PubMed=1998498; DOI=10.1016/S0006-291X(05)81209-4;
RA   Martin H., Dean M.;
RT   "Identification of a thioredoxin-related protein associated with
RT   plasma membranes.";
RL   Biochem. Biophys. Res. Commun. 175:123-128(1991).
RN   [16]
RP   PROTEIN SEQUENCE OF 9-48; 73-81 AND 95-105, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [17]
RP   FUNCTION.
RX   PubMed=2176490; DOI=10.1016/S0006-291X(05)80940-4;
RA   Jacquot J.-P., de Lamotte F., Fontecav M., Schuermann P.,
RA   Decottignies P., Miginiac-Maslow M., Wollman E.;
RT   "Human thioredoxin reactivity-structure/function relationship.";
RL   Biochem. Biophys. Res. Commun. 173:1375-1381(1990).
RN   [18]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1332947;
RA   Rubartelli A., Bajetto A., Allavena G., Wollman E., Sitia R.;
RT   "Secretion of thioredoxin by normal and neoplastic cells through a
RT   leaderless secretory pathway.";
RL   J. Biol. Chem. 267:24161-24164(1992).
RN   [19]
RP   FUNCTION, SUBUNIT, INTERACTION WITH APEX1, MUTAGENESIS OF CYS-32;
RP   CYS-35; CYS-62; CYS-69 AND CYS-73, AND SUBCELLULAR LOCATION.
RX   PubMed=9108029; DOI=10.1073/pnas.94.8.3633;
RA   Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., Yodoi J.;
RT   "AP-1 transcriptional activity is regulated by a direct association
RT   between thioredoxin and Ref-1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:3633-3638(1997).
RN   [20]
RP   FUNCTION, INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11118054;
RA   Wei S.J., Botero A., Hirota K., Bradbury C.M., Markovina S.,
RA   Laszlo A., Spitz D.R., Goswami P.C., Yodoi J., Gius D.;
RT   "Thioredoxin nuclear translocation and interaction with redox factor-1
RT   activates the activator protein-1 transcription factor in response to
RT   ionizing radiation.";
RL   Cancer Res. 60:6688-6695(2000).
RN   [21]
RP   S-NITROSYLATION, AND INTERACTION WITH MAP3K5.
RX   PubMed=15246877; DOI=10.1016/j.abb.2004.06.004;
RA   Yasinska I.M., Kozhukhar A.V., Sumbayev V.V.;
RT   "S-nitrosation of thioredoxin in the nitrogen monoxide/superoxide
RT   system activates apoptosis signal-regulating kinase 1.";
RL   Arch. Biochem. Biophys. 428:198-203(2004).
RN   [22]
RP   FUNCTION, MUTAGENESIS OF CYS-73, AND S-NITROSYLATION AT CYS-73.
RX   PubMed=16408020; DOI=10.1038/nchembio720;
RA   Mitchell D.A., Marletta M.A.;
RT   "Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site
RT   cysteine.";
RL   Nat. Chem. Biol. 1:154-158(2005).
RN   [23]
RP   FUNCTION, MUTAGENESIS OF CYS-69; GLU-70; LYS-72 AND CYS-73, AND
RP   S-NITROSYLATION AT CYS-73 IN RESPONSE TO NITRIC OXIDE.
RX   PubMed=17606900; DOI=10.1073/pnas.0704898104;
RA   Mitchell D.A., Morton S.U., Fernhoff N.B., Marletta M.A.;
RT   "Thioredoxin is required for S-nitrosation of procaspase-3 and the
RT   inhibition of apoptosis in Jurkat cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:11609-11614(2007).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RA   Ahamed M.E., Ahmed M.E., Eltoum A.M., Altahir G.O., Ahmed K.M.,
RA   Harbi S.O., Stansalas J., Mohamed A.O.;
RT   "Abnormal proteins in primary breast cancer tissues from 25 Sudanese
RT   patients.";
RL   Eur. J. Inflamm. 6:115-121(2008).
RN   [25]
RP   INTERACTION WITH S.TYPHIMURIUM SLRP, AND UBIQUITINATION.
RX   PubMed=19690162; DOI=10.1074/jbc.M109.010363;
RA   Bernal-Bayard J., Ramos-Morales F.;
RT   "Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase
RT   for mammalian thioredoxin.";
RL   J. Biol. Chem. 284:27587-27595(2009).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-3 AND LYS-39, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [30]
RP   STRUCTURE BY NMR.
RX   PubMed=2684271; DOI=10.1021/bi00443a045;
RA   Forman-Kay J.D., Clore G.M., Dricoll P.C., Wingfield P.,
RA   Richards F.M., Gronenborn A.M.;
RT   "A proton nuclear magnetic resonance assignment and secondary
RT   structure determination of recombinant human thioredoxin.";
RL   Biochemistry 28:7088-7097(1989).
RN   [31]
RP   STRUCTURE BY NMR.
RX   PubMed=2001356; DOI=10.1021/bi00224a017;
RA   Forman-Kay J.D., Clore G.M., Wingfield P., Gronenborn A.M.;
RT   "High-resolution three-dimensional structure of reduced recombinant
RT   human thioredoxin in solution.";
RL   Biochemistry 30:2685-2698(1991).
RN   [32]
RP   STRUCTURE BY NMR.
RX   PubMed=7922028; DOI=10.1016/S0969-2126(00)00051-4;
RA   Qin J., Clore G.M., Gronenborn A.M.;
RT   "The high-resolution three-dimensional solution structures of the
RT   oxidized and reduced states of human thioredoxin.";
RL   Structure 2:503-522(1994).
RN   [33]
RP   STRUCTURE BY NMR.
RX   PubMed=7788295; DOI=10.1016/S0969-2126(01)00159-9;
RA   Qin J., Clore G.M., Kennedy W.M., Huth J.R., Gronenborn A.M.;
RT   "Solution structure of human thioredoxin in a mixed disulfide
RT   intermediate complex with its target peptide from the transcription
RT   factor NF kappa B.";
RL   Structure 3:289-297(1995).
RN   [34]
RP   STRUCTURE BY NMR.
RX   PubMed=8736558; DOI=10.1016/S0969-2126(96)00065-2;
RA   Qin J., Clore G.M., Kennedy W.P., Kuszewski J., Gronenborn A.M.;
RT   "The solution structure of human thioredoxin complexed with its target
RT   from Ref-1 reveals peptide chain reversal.";
RL   Structure 4:613-620(1996).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS).
RX   PubMed=8805557; DOI=10.1016/S0969-2126(96)00079-2;
RA   Weichsel A., Gasdaska J.R., Powis G., Montfort W.R.;
RT   "Crystal structures of reduced, oxidized, and mutated human
RT   thioredoxins: evidence for a regulatory homodimer.";
RL   Structure 4:735-751(1996).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF MUTANT ASN-60, AND SUBUNIT.
RX   PubMed=9369469; DOI=10.1021/bi971004s;
RA   Andersen J.F., Sanders D.A., Gasdaska J.R., Weichsel A., Powis G.,
RA   Montfort W.R.;
RT   "Human thioredoxin homodimers: regulation by pH, role of aspartate 60,
RT   and crystal structure of the aspartate 60 --> asparagine mutant.";
RL   Biochemistry 36:13979-13988(1997).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS), SUBUNIT, DISULFIDE BONDS, AND
RP   S-NITROSYLATION AT CYS-62 AND CYS-69.
RX   PubMed=17260951; DOI=10.1021/bi061878r;
RA   Weichsel A., Brailey J.L., Montfort W.R.;
RT   "Buried S-nitrosocysteine revealed in crystal structures of human
RT   thioredoxin.";
RL   Biochemistry 46:1219-1227(2007).
CC   -!- FUNCTION: Participates in various redox reactions through the
CC       reversible oxidation of its active center dithiol to a disulfide
CC       and catalyzes dithiol-disulfide exchange reactions. Plays a role
CC       in the reversible S-nitrosylation of cysteine residues in target
CC       proteins, and thereby contributes to the response to intracellular
CC       nitric oxide. Nitrosylates the active site Cys of CASP3 in
CC       response to nitric oxide (NO), and thereby inhibits caspase-3
CC       activity. Induces the FOS/JUN AP-1 DNA-binding activity in
CC       ionizing radiation (IR) cells through its oxidation/reduction
CC       status and stimulates AP-1 transcriptional activity.
CC   -!- FUNCTION: ADF augments the expression of the interleukin-2
CC       receptor TAC (IL2R/P55).
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Interacts with TXNIP through
CC       the redox-active site. Interacts with MAP3K5 and CASP3. In case of
CC       infection, interacts with S.typhimurium protein slrP. Interacts
CC       with APEX1; the interaction stimulates the FOS/JUN AP-1 DNA-
CC       binding activity in a redox-dependent manner.
CC       {ECO:0000269|PubMed:15246877, ECO:0000269|PubMed:17260951,
CC       ECO:0000269|PubMed:19690162, ECO:0000269|PubMed:9108029,
CC       ECO:0000269|PubMed:9369469}.
CC   -!- INTERACTION:
CC       Q92905:COPS5; NbExp=8; IntAct=EBI-594644, EBI-594661;
CC       P00533:EGFR; NbExp=4; IntAct=EBI-594644, EBI-297353;
CC       Q99683:MAP3K5; NbExp=2; IntAct=EBI-594644, EBI-476263;
CC       Q99836:MYD88; NbExp=4; IntAct=EBI-594644, EBI-447677;
CC       P18031:PTPN1; NbExp=2; IntAct=EBI-594644, EBI-968788;
CC       D0ZRB2:slrP (xeno); NbExp=7; IntAct=EBI-594644, EBI-10762386;
CC       Q9NZD8:SPG21; NbExp=4; IntAct=EBI-594644, EBI-742688;
CC       Q9H3M7:TXNIP; NbExp=4; IntAct=EBI-594644, EBI-1369170;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11118054,
CC       ECO:0000269|PubMed:9108029}. Cytoplasm
CC       {ECO:0000269|PubMed:11118054, ECO:0000269|PubMed:9108029}.
CC       Secreted {ECO:0000269|PubMed:1332947}. Note=Translocates from the
CC       cytoplasm into the nucleus after phorbol 12-myristate 13-acetate
CC       induction (PMA) (PubMed:9108029). Predominantly in the cytoplasm
CC       in non irradiated cells (PubMed:11118054). Radiation induces
CC       translocation of TRX from the cytoplasm to the nucleus
CC       (PubMed:11118054). Secreted by a leaderless secretory pathway
CC       (PubMed:1332947). {ECO:0000269|PubMed:11118054,
CC       ECO:0000269|PubMed:1332947, ECO:0000269|PubMed:9108029}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P10599-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P10599-2; Sequence=VSP_045607;
CC   -!- INDUCTION: Up-regulated by ionizing radiation.
CC       {ECO:0000269|PubMed:11118054}.
CC   -!- PTM: In the fully reduced protein, both Cys-69 and Cys-73 are
CC       nitrosylated in response to nitric oxide (NO). When two disulfide
CC       bonds are present in the protein, only Cys-73 is nitrosylated.
CC       Cys-73 can serve as donor for nitrosylation of target proteins.
CC       {ECO:0000269|PubMed:15246877, ECO:0000269|PubMed:16408020,
CC       ECO:0000269|PubMed:17260951, ECO:0000269|PubMed:17606900}.
CC   -!- PTM: In case of infection, ubiquitinated by S.typhimurium protein
CC       slrP, leading to its degradation. {ECO:0000269|PubMed:19690162}.
CC   -!- SIMILARITY: Belongs to the thioredoxin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/txn/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TXNID44354ch9q31.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J04026; AAA74596.1; -; mRNA.
DR   EMBL; X77584; CAA54687.1; -; mRNA.
DR   EMBL; X54539; CAA38410.1; -; Genomic_DNA.
DR   EMBL; X54540; CAA38410.1; JOINED; Genomic_DNA.
DR   EMBL; X54541; CAA38410.1; JOINED; Genomic_DNA.
DR   EMBL; AF276919; AAF86466.1; -; mRNA.
DR   EMBL; AY004872; AAF87085.1; -; mRNA.
DR   EMBL; AF313911; AAG34699.1; -; mRNA.
DR   EMBL; AK289508; BAF82197.1; -; mRNA.
DR   EMBL; CR407665; CAG28593.1; -; mRNA.
DR   EMBL; AF548001; AAN33187.1; -; Genomic_DNA.
DR   EMBL; AL158158; CAI14066.1; -; Genomic_DNA.
DR   EMBL; AL158158; CAI14067.1; -; Genomic_DNA.
DR   EMBL; CH471105; EAW59059.1; -; Genomic_DNA.
DR   EMBL; CH471105; EAW59060.1; -; Genomic_DNA.
DR   EMBL; BC003377; AAH03377.1; -; mRNA.
DR   EMBL; BC054866; AAH54866.1; -; mRNA.
DR   EMBL; AF065241; AAC17430.1; -; mRNA.
DR   CCDS; CCDS35103.1; -. [P10599-1]
DR   CCDS; CCDS59139.1; -. [P10599-2]
DR   PIR; JH0568; JH0568.
DR   RefSeq; NP_001231867.1; NM_001244938.1. [P10599-2]
DR   RefSeq; NP_003320.2; NM_003329.3. [P10599-1]
DR   UniGene; Hs.435136; -.
DR   PDB; 1AIU; X-ray; 2.00 A; A=1-105.
DR   PDB; 1AUC; X-ray; 2.10 A; A=1-105.
DR   PDB; 1CQG; NMR; -; A=1-105.
DR   PDB; 1CQH; NMR; -; A=1-105.
DR   PDB; 1ERT; X-ray; 1.70 A; A=1-105.
DR   PDB; 1ERU; X-ray; 2.10 A; A=1-105.
DR   PDB; 1ERV; X-ray; 1.65 A; A=1-105.
DR   PDB; 1ERW; X-ray; 1.80 A; A=1-105.
DR   PDB; 1M7T; NMR; -; A=1-66.
DR   PDB; 1MDI; NMR; -; A=1-105.
DR   PDB; 1MDJ; NMR; -; A=1-105.
DR   PDB; 1MDK; NMR; -; A=1-105.
DR   PDB; 1TRS; NMR; -; A=1-105.
DR   PDB; 1TRU; NMR; -; A=1-105.
DR   PDB; 1TRV; NMR; -; A=1-105.
DR   PDB; 1TRW; NMR; -; A=1-105.
DR   PDB; 1W1C; Model; -; C=1-105.
DR   PDB; 1W1E; Model; -; C=1-105.
DR   PDB; 2HSH; X-ray; 1.35 A; A=1-105.
DR   PDB; 2HXK; X-ray; 1.65 A; A/B/C=1-105.
DR   PDB; 2IFQ; X-ray; 1.20 A; A/B/C=1-105.
DR   PDB; 2IIY; X-ray; 1.70 A; A=1-105.
DR   PDB; 3E3E; X-ray; 2.01 A; A/B=1-105.
DR   PDB; 3KD0; X-ray; 1.70 A; A=1-105.
DR   PDB; 3M9J; X-ray; 1.10 A; A/B=1-105.
DR   PDB; 3M9K; X-ray; 1.50 A; A/B=1-105.
DR   PDB; 3QFA; X-ray; 2.20 A; C/D=2-105.
DR   PDB; 3QFB; X-ray; 2.60 A; C/D=2-105.
DR   PDB; 3TRX; NMR; -; A=1-105.
DR   PDB; 4LL1; X-ray; 2.00 A; B/D=1-105.
DR   PDB; 4LL4; X-ray; 2.70 A; B/D=1-105.
DR   PDB; 4OO4; X-ray; 0.97 A; A/B=1-105.
DR   PDB; 4OO5; X-ray; 1.54 A; A=1-105.
DR   PDB; 4POK; X-ray; 2.52 A; A/B/C/D=1-105.
DR   PDB; 4POL; X-ray; 2.80 A; A/B/C/D=1-105.
DR   PDB; 4POM; X-ray; 1.85 A; A/B/C/D=1-105.
DR   PDB; 4PUF; X-ray; 3.30 A; C/D=1-105.
DR   PDB; 4TRX; NMR; -; A=1-105.
DR   PDB; 5DQY; X-ray; 1.40 A; A=1-105.
DR   PDBsum; 1AIU; -.
DR   PDBsum; 1AUC; -.
DR   PDBsum; 1CQG; -.
DR   PDBsum; 1CQH; -.
DR   PDBsum; 1ERT; -.
DR   PDBsum; 1ERU; -.
DR   PDBsum; 1ERV; -.
DR   PDBsum; 1ERW; -.
DR   PDBsum; 1M7T; -.
DR   PDBsum; 1MDI; -.
DR   PDBsum; 1MDJ; -.
DR   PDBsum; 1MDK; -.
DR   PDBsum; 1TRS; -.
DR   PDBsum; 1TRU; -.
DR   PDBsum; 1TRV; -.
DR   PDBsum; 1TRW; -.
DR   PDBsum; 1W1C; -.
DR   PDBsum; 1W1E; -.
DR   PDBsum; 2HSH; -.
DR   PDBsum; 2HXK; -.
DR   PDBsum; 2IFQ; -.
DR   PDBsum; 2IIY; -.
DR   PDBsum; 3E3E; -.
DR   PDBsum; 3KD0; -.
DR   PDBsum; 3M9J; -.
DR   PDBsum; 3M9K; -.
DR   PDBsum; 3QFA; -.
DR   PDBsum; 3QFB; -.
DR   PDBsum; 3TRX; -.
DR   PDBsum; 4LL1; -.
DR   PDBsum; 4LL4; -.
DR   PDBsum; 4OO4; -.
DR   PDBsum; 4OO5; -.
DR   PDBsum; 4POK; -.
DR   PDBsum; 4POL; -.
DR   PDBsum; 4POM; -.
DR   PDBsum; 4PUF; -.
DR   PDBsum; 4TRX; -.
DR   PDBsum; 5DQY; -.
DR   ProteinModelPortal; P10599; -.
DR   SMR; P10599; -.
DR   BioGrid; 113146; 115.
DR   DIP; DIP-6129N; -.
DR   IntAct; P10599; 49.
DR   MINT; MINT-1522967; -.
DR   STRING; 9606.ENSP00000363641; -.
DR   BindingDB; P10599; -.
DR   ChEMBL; CHEMBL2010624; -.
DR   Allergome; 3543; Hom s Trx.
DR   iPTMnet; P10599; -.
DR   PhosphoSitePlus; P10599; -.
DR   SwissPalm; P10599; -.
DR   BioMuta; TXN; -.
DR   DMDM; 135773; -.
DR   DOSAC-COBS-2DPAGE; P10599; -.
DR   REPRODUCTION-2DPAGE; IPI00216298; -.
DR   SWISS-2DPAGE; P10599; -.
DR   EPD; P10599; -.
DR   MaxQB; P10599; -.
DR   PaxDb; P10599; -.
DR   PeptideAtlas; P10599; -.
DR   PRIDE; P10599; -.
DR   TopDownProteomics; P10599-1; -. [P10599-1]
DR   TopDownProteomics; P10599-2; -. [P10599-2]
DR   DNASU; 7295; -.
DR   Ensembl; ENST00000374515; ENSP00000363639; ENSG00000136810. [P10599-2]
DR   Ensembl; ENST00000374517; ENSP00000363641; ENSG00000136810. [P10599-1]
DR   GeneID; 7295; -.
DR   KEGG; hsa:7295; -.
DR   UCSC; uc004bep.3; human. [P10599-1]
DR   CTD; 7295; -.
DR   DisGeNET; 7295; -.
DR   GeneCards; TXN; -.
DR   HGNC; HGNC:12435; TXN.
DR   HPA; CAB008678; -.
DR   HPA; HPA047478; -.
DR   HPA; HPA055752; -.
DR   MIM; 187700; gene.
DR   neXtProt; NX_P10599; -.
DR   OpenTargets; ENSG00000136810; -.
DR   PharmGKB; PA37091; -.
DR   eggNOG; KOG0907; Eukaryota.
DR   eggNOG; COG0526; LUCA.
DR   GeneTree; ENSGT00530000063008; -.
DR   HOGENOM; HOG000292977; -.
DR   HOVERGEN; HBG009243; -.
DR   InParanoid; P10599; -.
DR   KO; K03671; -.
DR   OMA; AISTHCA; -.
DR   OrthoDB; EOG091G01FG; -.
DR   PhylomeDB; P10599; -.
DR   TreeFam; TF318932; -.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5676934; Protein repair.
DR   Reactome; R-HSA-844456; The NLRP3 inflammasome.
DR   SignaLink; P10599; -.
DR   SIGNOR; P10599; -.
DR   ChiTaRS; TXN; human.
DR   EvolutionaryTrace; P10599; -.
DR   GeneWiki; Thioredoxin; -.
DR   GenomeRNAi; 7295; -.
DR   PRO; PR:P10599; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000136810; -.
DR   CleanEx; HS_TXN; -.
DR   ExpressionAtlas; P10599; baseline and differential.
DR   Genevisible; P10599; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0016671; F:oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor; IBA:GO_Central.
DR   GO; GO:0015037; F:peptide disulfide oxidoreductase activity; IEA:Ensembl.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; IBA:GO_Central.
DR   GO; GO:0047134; F:protein-disulfide reductase activity; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0004791; F:thioredoxin-disulfide reductase activity; IBA:GO_Central.
DR   GO; GO:0032148; P:activation of protein kinase B activity; IC:ParkinsonsUK-UCL.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0045454; P:cell redox homeostasis; IBA:GO_Central.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0006662; P:glycerol ether metabolic process; IEA:InterPro.
DR   GO; GO:0006928; P:movement of cell or subcellular component; TAS:ProtInc.
DR   GO; GO:1903206; P:negative regulation of hydrogen peroxide-induced cell death; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0046826; P:negative regulation of protein export from nucleus; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IGI:ParkinsonsUK-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IC:ParkinsonsUK-UCL.
DR   GO; GO:0030091; P:protein repair; TAS:Reactome.
DR   GO; GO:0033158; P:regulation of protein import into nucleus, translocation; IDA:UniProtKB.
DR   GO; GO:0009314; P:response to radiation; IDA:UniProtKB.
DR   GO; GO:0000302; P:response to reactive oxygen species; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR005746; Thioredoxin.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR017937; Thioredoxin_CS.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   PANTHER; PTHR10438; PTHR10438; 1.
DR   Pfam; PF00085; Thioredoxin; 1.
DR   PIRSF; PIRSF000077; Thioredoxin; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS00194; THIOREDOXIN_1; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disulfide bond; Electron transport; Nucleus; Redox-active center;
KW   Reference proteome; S-nitrosylation; Secreted; Transcription;
KW   Transcription regulation; Transport; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:1998498,
FT                                ECO:0000269|PubMed:7818492}.
FT   CHAIN         2    105       Thioredoxin.
FT                                /FTId=PRO_0000120005.
FT   DOMAIN        2    105       Thioredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   ACT_SITE     32     32       Nucleophile.
FT   ACT_SITE     35     35       Nucleophile.
FT   SITE         26     26       Deprotonates C-terminal active site Cys.
FT   SITE         33     33       Contributes to redox potential value.
FT   SITE         34     34       Contributes to redox potential value.
FT   MOD_RES       3      3       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES       8      8       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P10639}.
FT   MOD_RES      39     39       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      62     62       S-nitrosocysteine.
FT                                {ECO:0000269|PubMed:17260951}.
FT   MOD_RES      69     69       S-nitrosocysteine.
FT                                {ECO:0000269|PubMed:17260951}.
FT   MOD_RES      73     73       S-nitrosocysteine; alternate.
FT                                {ECO:0000269|PubMed:16408020,
FT                                ECO:0000269|PubMed:17606900}.
FT   MOD_RES      94     94       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P10639}.
FT   MOD_RES      94     94       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P10639}.
FT   DISULFID     32     35       Redox-active. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691,
FT                                ECO:0000269|PubMed:17260951,
FT                                ECO:0000269|PubMed:2001356}.
FT   DISULFID     73     73       Interchain; alternate.
FT                                {ECO:0000269|PubMed:17260951}.
FT   VAR_SEQ      44     63       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.13}.
FT                                /FTId=VSP_045607.
FT   MUTAGEN      32     32       C->S: Loses its reducing activity,
FT                                interaction with APEX1 and transcription
FT                                activation; when associated with S-35.
FT                                {ECO:0000269|PubMed:9108029}.
FT   MUTAGEN      35     35       C->S: Loses its reducing activity,
FT                                interaction with APEX1 and transcription
FT                                activation; when associated with S-32.
FT                                {ECO:0000269|PubMed:9108029}.
FT   MUTAGEN      60     60       D->N: Loss of pH-dependence of
FT                                dimerization.
FT   MUTAGEN      62     62       C->S: Retains its reducing activity.
FT                                Retains interaction with APEX1 and
FT                                transcription activation; when associated
FT                                with S-69 and S-73.
FT                                {ECO:0000269|PubMed:9108029}.
FT   MUTAGEN      69     69       C->S: No effect on reducing activity,
FT                                interaction with APEX1 and on S-
FT                                nitrosylation of C-73. Retains
FT                                interaction with APEX1 and transcription
FT                                activation; when associated with S-62 and
FT                                S-73. {ECO:0000269|PubMed:17606900,
FT                                ECO:0000269|PubMed:9108029}.
FT   MUTAGEN      70     70       E->A: Strongly reduced interaction with
FT                                CASP3; when associated with A-72.
FT                                {ECO:0000269|PubMed:17606900}.
FT   MUTAGEN      72     72       K->A: Strongly reduced interaction with
FT                                CASP3; when associated with A-70.
FT                                {ECO:0000269|PubMed:17606900}.
FT   MUTAGEN      73     73       C->D: Strongly reduced S-nitrosylation of
FT                                CASP3. {ECO:0000269|PubMed:16408020,
FT                                ECO:0000269|PubMed:17606900,
FT                                ECO:0000269|PubMed:9108029}.
FT   MUTAGEN      73     73       C->S: Loss of nitrosylation, and loss of
FT                                S-nitrosylating activity towards CASP3.
FT                                Retains interaction with APEX1 and
FT                                transcription activation; when associated
FT                                with S-62 and S-69.
FT                                {ECO:0000269|PubMed:16408020,
FT                                ECO:0000269|PubMed:17606900,
FT                                ECO:0000269|PubMed:9108029}.
FT   MUTAGEN      73     73       C->S: Retains its reducing activity.
FT                                {ECO:0000269|PubMed:16408020,
FT                                ECO:0000269|PubMed:17606900,
FT                                ECO:0000269|PubMed:9108029}.
FT   CONFLICT     39     39       K -> N (in Ref. 1; AAA74596 and 4;
FT                                AAF86466). {ECO:0000305}.
FT   CONFLICT     74     74       M -> T (in Ref. 1; AAA74596 and 4;
FT                                AAF86466). {ECO:0000305}.
FT   STRAND        3      5       {ECO:0000244|PDB:2IFQ}.
FT   HELIX         8     17       {ECO:0000244|PDB:4OO4}.
FT   TURN         18     20       {ECO:0000244|PDB:4OO4}.
FT   STRAND       23     28       {ECO:0000244|PDB:4OO4}.
FT   STRAND       30     32       {ECO:0000244|PDB:4TRX}.
FT   HELIX        33     48       {ECO:0000244|PDB:4OO4}.
FT   TURN         49     51       {ECO:0000244|PDB:3QFB}.
FT   STRAND       52     58       {ECO:0000244|PDB:4OO4}.
FT   TURN         59     62       {ECO:0000244|PDB:4OO4}.
FT   HELIX        63     69       {ECO:0000244|PDB:4OO4}.
FT   STRAND       73     81       {ECO:0000244|PDB:4OO4}.
FT   STRAND       84     91       {ECO:0000244|PDB:4OO4}.
FT   HELIX        94    104       {ECO:0000244|PDB:4OO4}.
SQ   SEQUENCE   105 AA;  11737 MW;  256F4E3C8A187693 CRC64;
     MVKQIESKTA FQEALDAAGD KLVVVDFSAT WCGPCKMIKP FFHSLSEKYS NVIFLEVDVD
     DCQDVASECE VKCMPTFQFF KKGQKVGEFS GANKEKLEAT INELV
//
